These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9326994)

  • 1. Abnormal skeletal muscle bioenergetics in familial hypertrophic cardiomyopathy.
    Thompson CH; Kemp GJ; Taylor DJ; Conway M; Rajagopalan B; O'Donoghue A; Styles P; McKenna WJ; Radda GK
    Heart; 1997 Aug; 78(2):177-81. PubMed ID: 9326994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy.
    Crilley JG; Boehm EA; Blair E; Rajagopalan B; Blamire AM; Styles P; McKenna WJ; Ostman-Smith I; Clarke K; Watkins H
    J Am Coll Cardiol; 2003 May; 41(10):1776-82. PubMed ID: 12767664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in cardiac energetics between patients with familial and nonfamilial hypertrophic cardiomyopathy.
    Jung WI; Hoess T; Bunse M; Widmaier S; Sieverding L; Breuer J; Apitz J; Schmidt O; van Erckelens F; Dietze GJ; Lutz O
    Circulation; 2000 Mar; 101(12):E121. PubMed ID: 10736302
    [No Abstract]   [Full Text] [Related]  

  • 4. Creatine kinase adenosine triphosphate and phosphocreatine energy supply in a single kindred of patients with hypertrophic cardiomyopathy.
    Abraham MR; Bottomley PA; Dimaano VL; Pinheiro A; Steinberg A; Traill TA; Abraham TP; Weiss RG
    Am J Cardiol; 2013 Sep; 112(6):861-6. PubMed ID: 23751935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.
    Spindler M; Saupe KW; Christe ME; Sweeney HL; Seidman CE; Seidman JG; Ingwall JS
    J Clin Invest; 1998 Apr; 101(8):1775-83. PubMed ID: 9541509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of cardiomyopathy mutation (R97L) in mouse cardiac troponin T on the muscle length-mediated recruitment of crossbridges is modified divergently by α- and β-myosin heavy chain.
    Gollapudi SK; Chandra M
    Arch Biochem Biophys; 2016 Jul; 601():105-12. PubMed ID: 26792537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.
    Sorajja P; Elliott PM; McKenna WJ
    Europace; 2000 Jan; 2(1):4-14. PubMed ID: 11225594
    [No Abstract]   [Full Text] [Related]  

  • 8. Bio-energetic impairment in human calf muscle in thyroid disorders: a 31P MRS study.
    Khushu S; Rana P; Sekhri T; Sripathy G; Tripathi RP
    Magn Reson Imaging; 2010 Jun; 28(5):683-9. PubMed ID: 20332062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance spectroscopy in congenital heart disease.
    Miall-Allen VM; Kemp GJ; Rajagopalan B; Taylor DJ; Radda GK; Haworth SG
    Heart; 1996 Jun; 75(6):614-9. PubMed ID: 8697167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calf muscle mitochondrial and glycogenolytic ATP synthesis in patients with claudication due to peripheral vascular disease analysed using 31P magnetic resonance spectroscopy.
    Kemp GJ; Hands LJ; Ramaswami G; Taylor DJ; Nicolaides A; Amato A; Radda GK
    Clin Sci (Lond); 1995 Dec; 89(6):581-90. PubMed ID: 8549076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestations of hypertrophic cardiomyopathy with mutations in the cardiac beta-myosin heavy chain gene or cardiac troponin T gene.
    Koga Y; Toshima H; Kimura A; Harada H; Koyanagi T; Nishi H; Nakata M; Imaizumi T
    J Card Fail; 1996 Dec; 2(4 Suppl):S97-103. PubMed ID: 8951566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malalignment of the sarcomeric filaments in hypertrophic cardiomyopathy with cardiac myosin heavy chain gene mutation.
    Muraishi A; Kai H; Adachi K; Nishi H; Imaizumi T
    Heart; 1999 Nov; 82(5):625-9. PubMed ID: 10525522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural effects of the slow/b-cardiac myosin heavy chain R453C mutation in cardiac and skeletal muscle.
    Tajsharghi H; Fyhr IM
    Scand Cardiovasc J; 2008 Apr; 42(2):153-6. PubMed ID: 18365899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hypertrophic cardiomyopathy associated with a novel missense mutation affecting the ATP-binding region of the cardiac beta-myosin heavy chain.
    Bundgaard H; Havndrup O; Andersen PS; Larsen LA; Brandt NJ; Vuust J; Kjeldsen K; Christiansen M
    J Mol Cell Cardiol; 1999 Apr; 31(4):745-50. PubMed ID: 10329202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure.
    Arbustini E; Fasani R; Morbini P; Diegoli M; Grasso M; Dal Bello B; Marangoni E; Banfi P; Banchieri N; Bellini O; Comi G; Narula J; Campana C; Gavazzi A; Danesino C; Viganò M
    Heart; 1998 Dec; 80(6):548-58. PubMed ID: 10065021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in the ratio of mutant to wildtype myosin heavy chain present in the soleus muscle of patients with familial hypertrophic cardiomyopathy. A new approach for the quantification of mutant to wildtype protein.
    Nier V; Schultz I; Brenner B; Forssmann W; Raida M
    FEBS Lett; 1999 Nov; 461(3):246-52. PubMed ID: 10567705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac and skeletal muscle expression of mutant β-myosin heavy chains, degree of functional impairment and phenotypic heterogeneity in hypertrophic cardiomyopathy.
    Di Domenico M; Casadonte R; Ricci P; Santini M; Frati G; Rizzo A; Carratelli CR; Lamberti M; Parrotta E; Quaresima B; Faniello CM; Costanzo F; Cuda G
    J Cell Physiol; 2012 Oct; 227(10):3471-6. PubMed ID: 22213221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
    Ramírez CD; Padrón R
    Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hypertrophic cardiomyopathy: functional effects of myosin mutation R723G in cardiomyocytes.
    Kraft T; Witjas-Paalberends ER; Boontje NM; Tripathi S; Brandis A; Montag J; Hodgkinson JL; Francino A; Navarro-Lopez F; Brenner B; Stienen GJ; van der Velden J
    J Mol Cell Cardiol; 2013 Apr; 57():13-22. PubMed ID: 23318932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities in exercising skeletal muscle in congestive heart failure can be explained in terms of decreased mitochondrial ATP synthesis, reduced metabolic efficiency, and increased glycogenolysis.
    Kemp GJ; Thompson CH; Stratton JR; Brunotte F; Conway M; Adamopoulos S; Arnolda L; Radda GK; Rajagopalan B
    Heart; 1996 Jul; 76(1):35-41. PubMed ID: 8774325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.